Skip to content

The development of the Non-language-based Cognitive Assessment (NLCA) and clinic application

The development of the Non-language-based Cognitive Assessment (NLCA) and clinic application

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-13003559
Enrollment
Unknown
Registered
2013-09-06
Start date
2013-08-23
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia

Interventions

Mild cognitive impairment:Measurement of the scale
Aphasia:Measurement of the scale
Normal controls:Measurement of the scale

Sponsors

Department of Neurology, Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aphasia patients (AP) (1) patients with stroke must be confirmed by CT and MRI; (2) patients must keep a stable mood and stay clear-minded; (3) patients must willingly cooperate for conditional visits; (4) the patients' aphasia needs to be identified and put into categories according to the Aphasia Battery of Chinese (ABC) and Benson; 2. Mild cognitive impairment (MCI)The Mayo Clinics criteria (Petersen et al., 1999; Petersen, 2004): (1) subjective cognitive complaint, preferably corroborated by a reliable informant; (2) objective cognitive impairment in the neuropsychological assessment; (3) preserved global intellectual function; (4) preserved or minimal impairment in activities of daily living; and (5) non-demented; 3. Normal controls (NC): (1) normal general physical status; (2) CDR = 0, independent in ADL; (3) no memory complaints; (4) the control group subjects match MCI patients on variables that were found to be predictive of the MoCA-BJs performance and additionally on gender.

Exclusion criteria

Exclusion criteria: 1. Aphasia patients (AP): (1) patients in coma, in unconscious state, and in vegetative state; (2) patients in serious condition, weak and not up for assessments, or those who unwillingly participate; (3) patients whose condition developed rapidly and acutely, deteriorated with signs of latest cerebral infarction or intracerebral hemorrhage, or internal organ dysfunction and failure; and (4) patients with subarachnoid hemorrhage, transient ischemic attack, or reversible ischemic neurological deficit; 2. Mild cognitive impairment (MCI): (1) metabolic conditions such as hypothyroidism or vitamin B12 or folic acid deficiencies; (2) psychiatric disorders such as schizophrenia or depression; (3) evident infarction or brain hemorrhaging as indicated by MR/CT imaging; or (4) Parkinsonian syndrome, epilepsy and other nervous system diseases; 3. Normal controls (NC)the subjects with kidney disease, thyroid gland disorders, drug abuse, or other diseases that may result in cognitive impairment were precluded.

Design outcomes

Primary

MeasureTime frame
The score of Non-linguistic Cognitive Assessment (NLCA) ;MoCA score;

Countries

China

Contacts

Public ContactXiaojia LIU
xiaojialiu07@hotmail.com+86 13660007311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026